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A B S T R A CT  
In type 2 diabetic patients, blood lipids and lipid ratios have been 
proven to be associated with atherosclerosis risk; however, 
results about the effect of gender differences had not been fully 
conclusive.  In this transversal comparative study, a total of 129 
adult type 2 diabetic patients (54 men and 75 women), from 
north western Algeria, was included to highlight the impact of 
gender differences on atherosclerosis risk (assessed by lipid 
ratios) according to their diabetic profile. Comparing between 
the two genders, no significant differences (p>0.05) were 
noted on diabetes duration, central obesity, body mass index 
and blood pressures. Moreover, the basic biochemical 
parameters of both glycaemic and lipid metabolism were not 
meaningfully divergent. However, higher significant values 
(p<0.05) of body weight, height, HbA1c levels, HDL and lipid 
ratios (TC/HDL, LDL/HDL and TG/HDL) were observed in 
male patients comparing to females. According to the HbA1c 
levels (HbA1c<7%vs. HbA1c≥ 7%); notable higher CT/HDL, 
LDL/HDL and TG/HDL in male patients comparing to 
women were found. The rates of these three lipid ratios were 
often higher in both classes of HbA1c. The consideration 
of gender differences is very important for prevention, 
diagnosis, treatment and management of atherosclerosis 
and CVD. The disparity in atherogenic risk, in both genders, 
estimated by lipid ratios need to be critically examined. Further, 
interventional studies are needed to determine how sex can 
modulate the impacts of diabetes control parameters on 
atherosclerosis risk. 
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1 Introduction 
Globally, an upsurge in number of people dying from cardiovascular disease (CVD) is expected to reach 
23.3 million by 2030 [1], [2]. The prevalence of atherosclerosis, which is the dominant cause of 
cardiovascular disease (CVD), is significantly higher in diabetic people comparing to those without the 
diabetic disease. The clinical associations between diabetes and atherosclerosis are now well established. 
Several observational studies suggest that damages on vascular homeostasis are due to the impact of chronic 
hyperglycaemia. Likewise, higher levels of the mediators of inflammation, such as C-reactive protein (CRP), 
interleukin-6 (IL-6), plasminogen activator inhibitor 1 (PAI-1), are observed in diabetic patients suggesting 
a positive correlation between diabetes and atherosclerosis [3]. Type 2 diabetes is, however, more associated 
to cardiovascular co-morbidities and mortality comparing to the other types of diabetes mellitus [4, 5]. As 
of 2016, the American Diabetes Association “ADA” has focused specifically in its treatment guidelines in 
type 2 diabetic disease on "atherosclerotic cardiovascular disease" and suspected peripheral arterial disease 
of atherosclerotic origin [6]. However, increasing evidence indicates that risk of atherosclerosis in type 2 
diabetic patients is different in women and men [7], [8].  
Dyslipidaemia, defined by elevated serum lipids, is one of the most significant risk factors for atherosclerosis 
[9]. There is contradictory data on the role of serum lipids and their ratios such as total cholesterol 
(TC)/high density lipoprotein (HDL), triglycerides (TG)/HDL, and low-density lipoprotein (LDL)/HDL 
in the promotion of atherosclerosis [10]. Though, several factors such as age, gender differences, 
anthropometric parameters, glycosylated haemoglobin level (HbA1c) and diabetes mellitus have been long-
established to be associated with the atherosclerosis risk. The objective of this study was therefore to assess 
the risk of atherosclerosis (estimated using serum lipid ratios) by comparing men and women with type 2 
diabetes, from the north western Algeria, according to their HbA1c level. 
2 Patients and Methods 
This is a transversal comparative study performed during four months, from November 2019 to February 
2020, and covered a total of 129 adult type 2 diabetic patients (54 men and 75 women) aged 30 to 80 years 
(64.17±10.77 years). This work took place in the Public Establishment of Proximity Health (diabetes centre 
Larbi Ben M’hidi; Ex Gambetta) in Sidi-Bel-Abbes, North-western Algeria. The source of information is 
based on medical records of diabetic patients. Data analysis were processed and performed manually using 
the Statistical Package for Social Sciences® (SPSS, version 24.0) and the Microsoft Excel 2013 program. 
Results are expressed as means ± standard deviations, the paired student t-test for independent samples 
was used for comparing this means values with statistical significance set at p=0.05. Lipid ratios indicating 
the atherogenic risk were compared between the two genders according the glycated haemoglobin level 
using box plots. 
3 Results 
Table 1 summarizes the comparison of basic characteristics between males and females type 2 diabetic 
patients involved in our study. No significant differences were highlighted for diabetes duration, waist 
circumference, body mass index (BMI) and blood pressures. Furthermore, biochemical parameters did not 
show any significant differences when comparing between the two genders, namely for; fasting glycaemia, 
main lipid parameters, albuminuria, creatinuria, urea and creatinine. However, higher significant values 
(p<0.05) of body weight, height, HbA1c levels, HDL and lipid ratios (TC/HDL, LDL/HDL and 
TG/HDL) were observed in male patients comparing to females. 
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Table 1: Comparison of basic characteristics between male and female patients 
variables All patients, n=129 Males, n=54 Females, n=75 p value* 
Age (years) 64.17±10.77 66.61±9.59 62.42±11.28 0.029 
Diabetes duration (years) 13.95±8.98 12.87±8.16 14.67±9.47 0.281 
Anthropometric parameters 
Weight (kg) 76.81±16.86 82.66±15.49 72.60±16.65 0.001 
Height (m) 162.45±8.43 169.06±6.66 157.82±6.17 0.000 
Waist circumference (cm) 107.31±12.14 108.75±10.88 106.34±12.93 0.353 
BMI (kg/m2) 29.33±6.56 29.29±6.68 29.36±6.52 0.953 
Blood pressure 
Systolic Blood Pressure (mmHg) 12.39±1.76 12.66±1.52 12.21±1.89 0.223 
Diastolic Blood Pressure (mmHg) 6.58±0.98 6.66±0.93 6.53±1.01 0.549 
Biochemical parameters 
Fasting glycaemia (g/l) 1.48±0.60 1.55±0.56 1.43±0.64 0.636 
HbA1c (%) 7.96±1.45 8.03±1.67 7.91±1.28 0.017 
Total cholesterol (g/l) 1.59±0.50 1.62±0.58 1.57±0.45 0.562 
HDL (g/l) 0.43±.10 0.39±0.10 0.46±0.10 0.002 
LDL (g/l) 0.98±0.38 0.98±0.47 0.98±0.31 0.903 
Triglycerides (g/l) 1.18±0.67 1.36±0.79 1.06±0.53 0.562 
Urea (g/l) 0.38±0.13 0.43±0.13 0.29±0.10 0.462 
Creatinine (g/l) 12.02±0.87 14.96±10.37 7.62±2.59 0.149 
Lipid ratios 
TC/HDL 3.80±1.36 4.20±1.52 3.52±1.18 0.009 
LDL/HDL 2.36±0.96 2.55±1.11 2.23±0.82 0.086 
TG/HDL 2.94±2.22 3.58±2.70 2.51±1.71 0.011 
(*) Comparison between males and females using Student’s t-test, a p<0.05 was considered as significant; BMI: body mass index; HbA1c: 
glycated haemoglobin; TC: total cholesterol; LDL: low-density lipoprotein cholesterol; HDL: high-density lipoprotein cholesterol; TG: 
triglycerides; ACR: Urine albumin to creatinine ratio. 
 
Our findings about the comparison of 
lipid ratios, between males and females 
with type 2 diabetes, according to the 
HbA1c levels (HbA1c<7% vs. HbA1c ≥ 
7%) revealed high levels of CT/HDL 
(figure 1. A), LDL/HDL (figure 1. B) and 
TG/HDL (figure 1. C) in male patients 
comparing to females. The rates of these 
three lipid ratios are often higher in both 
classes of HbA1c. 
 
 
 
 
 
 
Figure 1. A: Comparison of total cholesterol/HDL ratio between males and females according to HbA1c level. 
54 
 
 ISSN: 2456-7108 
Available online at Journals.aijr.in 
Impact of Gender Differences and Glycated Haemoglobin on Atherosclerosis Risk in Type 2 Diabetic Patients from North Western Algeria 
 
Figure 1. B: Comparison of total LDL/HDL ratio 
between males and females according to HbA1c level. 
Figure 1. C: Comparison of triglycerides/HDL ratio 
between males and females according to HbA1c level. 
 
The comparison of traditional lipid parameters (TC, 
LDL and TG) between males and females according 
to the HbA1c levels indicated higher total 
cholesterol rates and LDL cholesterol in females 
with HbA1c≥ 7% (figure 2. B). Nonetheless, total 
cholesterol (figure 2. A), LDL and triglycerides 
(figure 2. C) rates were higher in male type 2 diabetic 
patients with either higher or lower levels of 
HbA1c.  
 
Figure 2. A: Comparison of total cholesterol level 
between males and females according to HbA1c level 
 
 
 
 
 
 
Figure 2. B: Comparison of LDL level between 
males and females according to HbA1c level 
Figure 2. C: Comparison of triglycerides level 
between males and females according to HbA1c level 
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. 
4 Discussion 
The number of people estimated to be affected by diabetes by 2045 is about 693 million [11]. Diabetes as 
a chronic non-communicable disease is one of the leading causes of death, due to a high incidence of 
cardiovascular complications and especially atherosclerosis as major cardiovascular disease (CVD) [12]. 
Atherosclerosis is considered as a leading cause of morbidity and mortality in both men and women. During 
recent decades, considerable research has been undergone to understand the pathophysiology of 
atherosclerosis [13]. Before atherosclerosis becomes apparent, it progresses silently for many years or 
decades. The key marker of atherosclerosis is dyslipidaemia defined by alterations of lipid parameters and 
more precisely of lipid ratios [14].  
The objective of the present study is to evaluate the effect of gender difference on atherosclerosis risk 
indices (lipid ratios) by comparing between well controlled type 2 diabetic patients (HbA1c<7%) and less 
controlled ones (HbA1c≥7%). 
According to literature, in type 2 diabetic population, an increase level of total cholesterol, LDL cholesterol, 
low HDL cholesterol level is an atherogenic lipid marker, and probably involves independent risk [15]. 
Whereas, when total cholesterol, HDL cholesterol, and total/HDL cholesterol ratio are compared between 
a healthy population and patients with atherosclerosis, the total/HDL cholesterol ratio is found to present 
a best atherogenic indices. This explains the best discriminatory power of total/HDL cholesterol ratio, as 
well as its great predictive capacity [16].  
Preliminary consequences from the present study showed significant differences between the two genders 
regarding age, body weight, BMI, HbA1c levels and lipid ratios (TC/HDL, LDL/HDL and TG/HDL). 
However, the whole studied parameters were higher in male gender. All the same, according to the 
atherosclerosis lipid indices (lipid ratios), males have a significant higher risk. According to literature, it is 
often assumed that yet more men die from atherosclerosis or coronary artery disease than women [17]-[19]. 
One of the reasons that men are at high risk of developing atherosclerosis can be explained in part by their 
propensity to adopt risky behaviors such as smoking or excessive alcohol consumption [20], [21]. In 
addition, men and women exhibit differences in heart structure and function, sex hormones and socio-
psychological characteristics [12]. However, after menopause, the risk of atherosclerosis-related diseases 
begins to increase in women and may even exceed that of men [13]. 
Our results point out that all TC/HDL and TG/HDL ratios were beyond the therapeutic target standards 
recognized by most authors (3.5 for TC/HDL and 3.0 for TG/HDL) [22], [23]. Likewise, the values of 
these ratios for men were often high compared to women.  
Our findings revealed that the LDL/HDL ratio values in the study population were higher in men 
comparing to women, however, underneath the target level for both men (3.0) and women (2.5) as 
recognized by Aderibigbe et al. (2018) [24]. These outcomes are in accordance with conclusions reported 
from Ghana [25] and Iran [26] but different from conclusions of Ballotari et al. (2017) from Italy 
enlightening that diabetes constitutes a higher cardiovascular risk for women than for men [27]. 
The comparison of the conventional lipid parameters (TC, LDL and TG) between men and women 
according to the HbA1c levels indicated divergent results. While the TC and LDL rates were higher in 
women with HbA1c ≥7%, the TG values were higher in men with both levels of HbA1c. However, the 
majority of these traditional lipid parameters were normal.  
Several studies report that diabetes increases the risk of cardiovascular disease two to three times in men 
and three to seven times in women [28], [29]. The causes of this superiority in women are multifactorial 
and can be linked to several risk factors such as a large involvement in inflammatory factors, the small size 
of the coronary vessels and to diabetes treatment in women who are generally less positive [7].   
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5 Conclusion 
Although the number of explanatory hypotheses for the mechanisms of gender effects in atherogenesis 
continues to increase, the exact cellular explanation for these differences is unknown. The consideration of 
gender differences is very important for prevention, diagnosis, treatment and management of 
atherosclerosis and CVD. The differences are certainly caused by innate genes and environmental 
influences. However, the disparity in atherogenic risk estimated by lipid ratios need to be critically examined. 
There is still a long way to go in order to understand the pathophysiological basis of the difference between 
males and females with regard to atherosclerosis.  
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